Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

19.04
-0.0250-0.13%
Volume:958.91K
Turnover:18.27M
Market Cap:1.21B
PE:-8.12
High:19.33
Open:18.82
Low:18.59
Close:19.06
52wk High:28.00
52wk Low:6.91
Shares:63.60M
Float Shares:47.12M
Volume Ratio:1.02
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3433
EPS(LYR):-3.1931
ROE:-89.18%
ROA:-33.59%
PB:0.42
PE(LYR):-5.96

Loading ...

Press Release: Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

Dow Jones
·
Apr 22

We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely

Simply Wall St.
·
Apr 21

Jade Biosciences announces annual shareholder meeting

Reuters
·
Apr 18

Jade Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
Apr 17

Jade Biosciences (JBIO) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Apr 06

Jade Biosciences Adopts 2026 Employment Inducement Stock Plan

TIPRANKS
·
Apr 03

Jade Biosciences launches inducement equity plan, reserves 1.75 million shares

Reuters
·
Apr 03

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 25

Jade Biosciences participates in a conference call with William Blair

TIPRANKS
·
Mar 19

Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Hyperfine (HYPR)

TIPRANKS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Tonix Pharma (TNXP)

TIPRANKS
·
Mar 16

Jade Biosciences Inc : Btig Raises Target Price to $39 From $28

THOMSON REUTERS
·
Mar 16

Jade Biosciences Is Maintained at Buy by BTIG

Dow Jones
·
Mar 16

Jade Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 11

Jade Biosciences price target raised to $23 from $17 at Guggenheim

TIPRANKS
·
Mar 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Dyne Therapeutics (DYN)

TIPRANKS
·
Mar 10

Jade Biosciences Price Target Maintained With a $24.00/Share by Wedbush

Dow Jones
·
Mar 09

William Blair Initiates Coverage on Jade Biosciences With Outperform Rating

MT Newswires Live
·
Mar 09